Agios Pharmaceuticals (AGIO) earnings, Jul 30, 2026: EPS +12%, stock −6.5%
In brief
Agios Pharmaceuticals reported on Jul 30, 2026. Earnings per share changed +12% year over year, 2.1% below the estimate; revenue +258%. The stock opened with a −15.8% gap and closed the day −6.5% (Jul 30, 2026). The stock is now 38.5% below its 52-week high, −30.2% over 12 months. Next report: Nov 5, 2026.
EPS vs estimate−2.1%
EPS, YoY+12%
Revenue, YoY+258%
Gap · day−15.8% · −6.5%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Jul 30, 2026 | −15.8% | −6.5% |
Next-quarter estimates, ratings and the AGIO chart are in the terminal.
Open the terminalFAQ
When is Agios Pharmaceuticals's next earnings report?
Nov 5, 2026. The date comes from daily data and is corrected if the company moves it.
How did Agios Pharmaceuticals stock react to the report?
Opening gap −15.8%, day's result −6.5%.
Did Agios Pharmaceuticals's earnings grow?
Earnings per share rose 12% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.